Routine assessment of cognitive function in older patients with hypertension seen by primary care physicians: why and how-a decision-making support from the working group on 'hypertension and the brain' of the European Society of Hypertension and from the European Geriatric Medicine Society.
Journal
Journal of hypertension
ISSN: 1473-5598
Titre abrégé: J Hypertens
Pays: Netherlands
ID NLM: 8306882
Informations de publication
Date de publication:
01 2021
01 2021
Historique:
entrez:
4
12
2020
pubmed:
5
12
2020
medline:
16
10
2021
Statut:
ppublish
Résumé
: The guidelines on hypertension recently published by the European Societies of Hypertension and Cardiology, have acknowledged cognitive function (and its decline) as a hypertension-mediated organ damage. In fact, brain damage can be the only hypertension-mediated organ damage in more than 30% of hypertensive patients, evolving undetected for several years if not appropriately screened; as long as undetected it cannot provide either corrective measures, nor adequate risk stratification of the hypertensive patient.The medical community dealing with older hypertensive patients should have a simple and pragmatic approach to early identify and precisely treat these patients. Both hypertension and cognitive decline are undeniably growing pandemics in developed or epidemiologically transitioning societies. Furthermore, there is a clear-cut connection between exposure to the increased blood pressure and development of cognitive decline.Therefore, a group of experts in the field from the European Society of Hypertension and from the European Geriatric Medicine Society gathered together to answer practical clinical questions that often face the physician when dealing with their hypertensive patients in a routine clinical practice. They elaborated a decision-making approach to help standardize such clinical evaluation.
Identifiants
pubmed: 33273363
doi: 10.1097/HJH.0000000000002621
pii: 00004872-202101000-00014
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
90-100Références
Hellmuth J, Rabinovici GD, Miller BL. The rise of pseudomedicine for dementia and brain health. JAMA 2019; 321:543–544.
Li G, Larson EB, Shofer JB, Crane PK, Gibbons LE, McCormick W, et al. Cognitive trajectory changes over 20 years before dementia diagnosis: a large cohort study. J Am Geriatr Soc 2017; 65:2627–2633.
Terrera GM, Brayne C, Matthews F. CC75C Study Collaboration Group, One size fits all? Why we need more sophisticated analytical methods in the explanation of trajectories of cognition in older age and their potential risk factors. Int Psychogeriatr 2010; 22:291–299.
Gorelick PB, Scuteri A, Black SE, DeCarli C, Greenberg SM, Iadecola C, et al. American Heart Association Stroke Council, Council on Epidemiology and Prevention, Council on Cardiovascular Nursing, Council on Cardiovascular Radiology and Intervention, and Council on Cardiovascular Surgery and Anesthesia, Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2011; 42:2672–2713.
Qiu C, Winblad B, Fratiglioni L. The age-dependent relation of blood pressure to cognitive function and dementia. Lancet Neurol 2005; 4:487–549.
Olsen MH, Angell SY, Asma S, Boutouyrie P, Burger D, Chirinos JA, et al. A call to action and a lifecourse strategy to address the global burden of raised blood pressure on current and future generations: the Lancet Commission on hypertension. Lancet 2016; 388:2665–2712.
Scuteri A, Lakatta EG. Bringing prevention in geriatrics: evidences from cardiovascular medicine supporting the new challenge. Exp Gerontol 2013; 48:64–68.
Collaborators GBDD, Global, regional, and national burden of Alzheimer's disease and other dementias, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol 2019; 18:88–106.
Alzheimer's Disease International, World Alzheimer's report 2015: the global impact of dementia. London: Alzheimer's Disease International; 2015.
World Health Organization. World Health Organization and Alzheimer's Disease International, World Health Organization, Dementia: a public health priority. Geneva: 2012.
World Health Organization, Towards a dementia plan: a WHO guide. 2018; Geneva: World Health Organization, https://www.who.int/mental_health/neurology/dementia/policy_guidance/en/https://www.who.int/mental_health/neurology/dementia/policy_guidance/en/ . [Accessed April 2019]; Hachinski V, et al. Implementing the proclamation of stroke and potentially preventable dementias. Int J Stroke 2018;13:780–786.
Gauthier S, Albert M, Fox N, Goedert M, Kivipelto M, Mestre-Ferrandiz J, Middleton LT. Why has therapy development for dementia failed in the last two decades? Alzheimers Dement 2016; 12:60–64.
Satizabal CL, Beiser AS, Chouraki V, Chêne G, Dufouil C, Seshadri S. Incidence of dementia over three decades in the Framingham Heart Study. N Engl J Med 2016; 374:523–532.
Sinnige J, Braspenning J, Schellevis F, Stirbu-Wagner I, Westert G, Korevaar J. The prevalence of disease clusters in older adults with multiple chronic diseases – a systematic literature review. PLoS One 2013; 8:e79641.
Tonelli M, Wiebe N, Straus S, Fortin M, Guthrie B, James MT, et al. Alberta Kidney Disease Network, Multimorbidity, dementia and healthcare in older people: a population-based cohort study. CMAJ Open 2017; 5:E623–E631.
Qiu C, Fratiglioni L. A major role for cardiovascular burden in age-related cognitive decline. Nat Rev Cardiol 2015; 12:267–277.
Walker KA, Sharrett AR, Wu A, Schneider ALC, Albert M, Lutsey PL, et al. Association of midlife to late-life blood pressure patterns with incident dementia. JAMA 2019; 322:535–545.
Launer LJ. Blood pressure control as an intervention to prevent dementia. Lancet Neurol 2019; 18:906–908.
Wang R, Laveskog A, Laukka EJ, Kalpouzos G, Bäckman L, Fratiglioni L, Qiu C. MRI load of cerebral microvascular lesions and neurodegeneration, cognitive decline, and dementia. Neurology 2018; 91:e1487–e1497.
Triantafyllou A, Ferreira JP, Kobayashi M, Micard E, Xie Y, Kearney-Schwartz A, et al. Longer duration of hypertension and MRI microvascular brain alterations are associated with lower hippocampal volumes in older individuals with hypertension. J Alzheimers Dis 2020; 74:227–235.
Fink HA, Jutkowitz E, McCarten JR, Hemmy LS, Butler M, Davila H, et al. Pharmacologic interventions to prevent cognitive decline, mild cognitive impairment, and clinical Alzheimer-type dementia: a systematic review. Ann Intern Med 2018; 168:39–51.
Vicario A, Cerezo GH, Coca A, Gaseck D, Zaninelli A, Lovic D, et al. ESH WG on Hypertension and Brain, Effects of antihypertensive drugs treatment on cognitive function: cognitive impairment, dementia and Alzheimer's disease. Rev Fed Arg Cardiol 2019; 48:98–106.
Williamson JD, Pajewski NM, Auchus AP, Bryan RN, Chelune G, Cheung AK, et al. SPRINT MIND Investigators for the SPRINT Research Group, Effect of intensive vs standard blood pressure control on probable dementia: a randomized clinical trial. JAMA 2019; 321:553–561.
Bosch J, O’Donnell M, Swaminathan B, Lonn EM, Sharma M, Dagenais G, et al. HOPE-3 Investigators, Effects of blood pressure and lipid lowering on cognition: results from the HOPE-3 study. Neurology 2019; 92:e1435–e1446.
Levi Marpillat N, Macquin-Mavier I, Tropeano AI, Bachoud-Levi AC, Maison P. Antihypertensive classes, cognitive decline and incidence of dementia: a network meta-analysis. J Hypertens 2013; 31:1073–1082.
Stuhec M, Keuschler J, Serra-Mestres J, Isetta M. Effects of different antihypertensive medication groups on cognitive function in older patients: a systematic review. Eur Psychiatry 2017; 46:1–15.
Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, et al. 2018 ESC/ESH guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension: the Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension. J Hypertens 2018; 36:1953–2041.
Godin O, Tzourio C, Maillard P, Mazoyer B, Dufouil C. Antihypertensive treatment and change in blood pressure are associated with the progression of white matter lesion volumes: the Three-City (3C)-Dijon Magnetic Resonance Imaging Study. Circulation 2011; 123:266–273.
Cho N, Hoshide S, Nishizawa M, Fujiwara T, Kario K. Relationship between blood pressure variability and cognitive function in elderly patients with good blood pressure control. Am J Hypertens 2018; 31:293–298.
Nagai M, Hoshide S, Ishikawa J, Shimada K, Kario K. Ambulatory blood pressure as an independent determinant of brain atrophy and cognitive function in elderly hypertension. J Hypertens 2008; 26:1636–1641.
Kario K, Matsuo T, Kobayashi H, Imiya M, Matsuo M, Shimada K. Nocturnal fall of blood pressure and silent cerebrovascular damage in elderly hypertensive patients. Advanced silent cerebrovascular damage in extreme dippers. Hypertension 1996; 27:130–135.
Scuteri A, Morrell CH, Orru’ M, AlGhatrif M, Saba PS, Terracciano A, et al. Gender specific profiles of white coat and masked hypertension impacts on arterial structure and function in the SardiNIA study. Int J Cardiol 2016; 217:92–98.
Freeman R, Wieling W, Axelrod FB, Benditt DG, Benarroch E, Biaggioni I, et al. Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome. Clin Auton Res 2011; 21:69–72.
Frewen J, Finucane C, Savva GM, Boyle G, Kenny RA. Orthostatic hypotension is associated with lower cognitive performance in adults aged 50 plus with supine hypertension. J Gerontol Ser A Biol Sci Med Sci 2014; 69:878–885.
Velseboer DC, de Haan RJ, Wieling W, Goldstein DS, de Bie RMA. Prevalence of orthostatic hypotension in Parkinson's disease: a systematic review and meta-analysis. Parkinsonism Relat Disord 2011; 17:724–729.
Andersson M, Hansson O, Minthon L, Ballard CG, Londos E. The period of hypotension following orthostatic challenge is prolonged in dementia with Lewy bodies. Int J Geriatr Psychiatry 2008; 23:192–198.
Udow SJ, Robertson AD, MacIntosh BJ, Espay AJ, Rowe JB, Lang AE, Masellis M. ‘Under pressure’: is there a link between orthostatic hypotension and cognitive impairment in α-synucleinopathies? J Neurol Neurosurg Psychiatry 2016; 87:1311–1321.
Sambati L, Calandra-Buonaura G, Poda R, Guaraldi P, Cortelli P. Orthostatic hypotension and cognitive impairment: a dangerous association? Neurol Sci 2014; 35:951–957.
Freidenberg DL, Shaffer LET, Macalester S, Fannin EA. Orthostatic hypotension in patients with dementia. Cogn Behav Neurol 2013; 26:105–120.
Press Y, Punchik B, Freud T. Orthostatic hypotension and drug therapy in patients at an outpatient comprehensive geriatric assessment unit. J Hypertens 2016; 34:351–358.
Redston MR, Hilmer SN, McLachlan AJ, Clough AJ, Gnjidic D. Prevalence of potentially inappropriate medication use in older inpatients with and without cognitive impairment: a systematic review. J Alzheimers Dis 2018; 61:1639–1652.
Matsumoto A, Satoh M, Kikuya M, Ohkubo T, Hirano M, Inoue R, et al. Day-to-day variability in home blood pressure is associated with cognitive decline: the Ohasama Study. Hypertension 2014; 63:1333–1338.
Onder G, Bonassi S, Abbatecola AM, Folino-Gallo P, Lapi F, Marchionni N, et al. Geriatrics Working Group of the Italian Medicines Agency (AIFA), High prevalence of poor quality drug prescribing in older individuals: a nationwide report from the Italian Medicines Agency (AIFA). J Gerontol A Biol Sci Med Sci 2014; 69:430–437.
Banegas JR, Guallar-Castillón P, Rodríguez-Artalejo F, Graciani A, López-García E, Ruilope LM. Association between awareness, treatment, and control of hypertension, and quality of life among older adults in Spain. Am J Hypertens 2006; 19:686–693.
Marcum ZA, Walker RL, Jones BL, Ramaprasan A, Gray SL, Dublin S, et al. Patterns of antihypertensive and statin adherence prior to dementia: findings from the adult changes in thought study. BMC Geriatr 2019; 19:41.
Scuteri A, Modestino A, Frattari A, Di Daniele N, Tesauro M. Occurrence of hypotension in older participants. Which 24-h ABPM parameter better correlate with? J Gerontol A Biol Sci Med Sci 2012; 67:804–810.
de Heus RAA, Olde Rikkert MGM, Tully PJ, Lawlor BA, Claassen JAHR. Blood pressure variability and progression of clinical Alzheimer disease. Hypertension 2019; 74:1172–1180.
Wolters FJ, Zonneveld HI, Hofman A, van der Lugt A, Koudstaal PJ, Vernooij MW, Ikram MA. Heart-Brain Connection Collaborative Research Group, Cerebral perfusion and the risk of dementia: a population-based study. Circulation 2017; 136:719–728.
Scuteri A, Tesauro M, Guglini L, Lauro D, Fini M, Di Daniele N. Aortic stiffness and hypotension episodes are associated with impaired cognitive function in older subjects with subjective complaints of memory loss. Int J Cardiol 2013; 169:371–377.
Laurent S, Boutouyrie P, Asmar R, Gautier I, Laloux B, Guize L, et al. Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension 2001; 37:1236–1241.
Nilsson PN, Laurent S, Cunha PG, Olsen MH, Rietzschel E, Franco OH, et al. Characteristics of healthy vascular ageing (HVA) in pooled population-based cohort studies: the global MARE consortium. J Hypertens 2018; 36:2340–2349.
Cunha PG, Cotter J, Oliveira P, Vila I, Boutouyrie P, Laurent S, et al. Pulse wave velocity distribution in a cohort study: from arterial stiffness to early vascular aging. J Hypertens 2015; 33:1438–1445.
Scuteri A, Rovella V, Alunni Fegatelli D, Tesauro M, Gabriele M, Di Daniele N. An operational definition of SHATS (Systemic Hemodynamic Atherosclerotic Syndrome): role of arterial stiffness and blood pressure variability in elderly hypertensive subjects. Int J Cardiol 2018; 263:132–137.
Lakatta EG, Alunni Fegatelli D, Morrell CH, Fiorillo E, Orru M, Delitala A, et al. Impact of stiffer arteries on the response to antihypertensive treatment: a longitudinal study of the SardiNIA Cohort. J Am Med Dir Assoc 2020; 21:720–725.
Scuteri A, Wang H. Pulse wave velocity as a marker of cognitive impairment in the elderly. J Alzheimers Dis 2014; 42: (Suppl 4): S401–S410.
van Sloten TT, Protogerou AD, Henry RM, Schram MT, Launer LJ, Stehouwer CD. Association between arterial stiffness, cerebral small vessel disease and cognitive impairment: a systematic review and meta-analysis. Neurosci Biobehav Rev 2015; 53:121–130.
Hajjar I, Goldstein FC, Martin GS, Quyyumi AA. Roles of arterial stiffness and blood pressure in hypertension-associated cognitive decline in healthy adults. Hypertension 2016; 67:171–175.
Lamballais S, Sajjad A, Leening MJG, Gaillard R, Franco OH, Mattace-Raso FUS, et al. Association of blood pressure and arterial stiffness with cognition in 2 population-based child and adult cohorts. J Am Heart Assoc 2018; 7:e009847.
Watfa G, Benetos A, Kearney-Schwartz A, Labat C, Gautier S, Hanon O, et al. PARTAGE Study Investigators, Do arterial hemodynamic parameters predict cognitive decline over a period of 2 years in individuals older than 80 years living in nursing homes? The PARTAGE Study. J Am Med Dir Assoc 2015; 16:598–602.
Kearney-Schwartz A, Rossignol P, Bracard S, Felblinger J, Fay R, Boivin JM, et al. Vascular structure and function is correlated to cognitive performance and white matter hyperintensities in older hypertensive patients with subjective memory complaints. Stroke 2009; 40:1229–1236.
Scuteri A, Mandas A. The hidden treasure of 24-h ambulatory blood pressure monitoring – assessing BP variability. J Clin Hypertens (Greenwich) 2019; 21:1795–1796.
Mitchell GF, van Buchem MA, Sigurdsson S, Gotal JD, Jonsdottir MK, Kjartansson O, et al. Arterial stiffness, pressure and flow pulsatility and brain structure and function: the age, gene/environment susceptibility – Reykjavik study. Brain 2011; 134 (Pt 11):3398–3407.
Lulita MF, Girouard H. Treating hypertension to prevent cognitive decline and dementia: re-opening the debate. Adv Exp Med Biol 2017; 956:447–473.
Tsoi KK, Chan JY, Hirai HW, Wong SY, Kwok TC. Cognitive tests to detect dementia: a systematic review and meta-analysis. JAMA Intern Med 2015; 175:1450–1458.
Moyer VA. U.S. Preventive Services Task Force, Screening for cognitive impairment in older adults: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2014; 160:791–797.
Pottie K, Rahal R, Jaramillo A, Birtwhistle R, Thombs BD, Singh H, et al. Canadian Task Force on Preventive Healthcare, Recommendations on screening for cognitive impairment in older adults. CMAJ 2016; 188:37–46.
Galvin JE, Sadowsky CH. NINCDS-ADRDA, Practical guidelines for the recognition and diagnosis of dementia. J Am Board Fam Med 2012; 25:367–382.
Folstein MF, Folstein SE, McHugh PR. Mini–Mental state: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12:189–198.
Nasreddine ZS, Phillips NA, Bedirian V, Charbonneau S, Whitehead V, Collin I, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 2005; 53:695–699.
Lam B, Middleton LE, Masellis M, Stuss DT, Harry RD, Kiss A, et al. Criterion and convergent validity of the Montreal Cognitive Assessment with screening and standardized neuropsychological testing. J Am Geriatr Soc 2013; 61:2181–2185.
Samieri C, Perier MC, Gaye B, Proust-Lima C, Helmer C, Dartigues JF, et al. Association of cardiovascular health level in older age with cognitive decline and incident dementia. JAMA 2018; 320:657–664.
Lane CA, Barnes J, Nicholas JM, Sudre CH, Cash DM, Parker TD, et al. Associations between blood pressure across adulthood and late-life brain structure and pathology in the neuroscience substudy of the 1946 British birth cohort (Insight 46): an epidemiological study. Lancet Neurol 2019; 18:942–952.
Henskens LH, van Oostenbrugge RJ, Kroon AA, Hofman PA, Lodder J, de Leeuw PW. Detection of silent cerebrovascular disease refines risk stratification of hypertensive patients. J Hypertens 2009; 27:846–853.
Naumczyk P, Sabisz A, Witkowska M, Graff B, Jodzio K, Gasecki D, et al. Compensatory functional reorganization may precede hypertension-related brain damage and cognitive decline: a functional magnetic resonance imaging study. J Hyperension 2017; 35:1252–1262.
Rönnemaa E, Zethelius B, Lannfelt L, Kilander L. Vascular risk factors and dementia: 40-year follow-up of a population-based cohort. Dement Geriatr Cogn Disord 2011; 31:460–466.
Dubois B, Feldman HH, Jacova C, Dekosky ST, Barberger-Gateau P, Cummings J, et al. Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria. Lancet Neurol 2007; 6:734–746.
Frisoni GB, Galluzzi S, Pantoni L, Filippi M. The effect of white matter lesions on cognition in the elderly – small but detectable. Nat Clin Pract Neurol 2007; 3:620–627.